Thrombospondin-1 (TSP-1) promotes the invasive properties of human breast cancer

Journal of Surgical Research

Volumn 63, Issue 1, 1996, Pages 39-43

  Wang, Thomas N ^a   Qian, Xiao Hua ^a   Granick, Mark S ^a   Solomon, Mark P ^a   Rothman, Vicki L ^a   Berger, David H ^a   Tuszynski, George P ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; PROTEIN ANTIBODY; THROMBOSPONDIN;

BREAST CANCER; CANCER INVASION; CELL STRAIN MCF 7; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0029931502     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1996.0219     Document Type: Conference Paper

References (37)

1. Adams, J., and Lawler, J. The thrombospondin family. Curr. Biol. 3: 188-190, 1993.
2. Baenziger, N. L., Brodie, G. N., and Majerus, P. W. Thrombin-sensitive protein of human platelet membranes. Proc. Natl. Acad. Sci. U.S.A. 68: 240-243, 1971.
3. Lawler, J. W., Slayter, H. S., and Coligan, J. E. Isolation and characterization of a high molecular weight glycoprotein from human blood platelets. J. Biol. Chem. 253: 8609-8616, 1978.
4. Lawler, J., and Hynes, R. O. The structure of human thrombospondin, an adhesive glycoprotein with multiple calcium-binding sites and homologies with several different proteins. J. Cell Biol. 103: 1635-1648, 1986.
5. Tuszynski, G. P., Srivastava, S., Switalska, H. I., Holt, J., Cierniewski, C. S., and Niewiarowski, S. The interaction of human thrombospondin with fibrinogen. J. Biol. Chem. 260: 12230-12245, 1985.
6. Mosher, D. F., Doyle, M. F., and Jaffe, E. A. Synthesis and secretion of thrombospondin by cultured human endothelial cells. J. Cell Biol. 93: 343-348, 1982.
7. Raugi, G. J., Mumby, S. M., Abbott-Brown, D., and Bornstein, P. Thrombospondin: Synthesis and secretion by cells in culture. J. Cell Biol. 95: 351-354, 1982.
8. Jaffe, E. A., Ruggiero, J. T., Leung, L. L. K., Doyle, M. J., McKeown-Longo, P. J., and Mosher, D. F. Cultured human fibroblasts synthesize and secrete thrombospondin and incorporate it into extracellular matrix. Proc. Natl. Acad. Sci. U.S.A. 80: 998-1002, 1986.
9. Jaffe, E. A., Ruggiero, J. T., and Falcone, D. J. Monocytes and macrophages synthesize and secrete thrombospondin. Blood, 65: 79-84, 1985.
10. Mosher, D. F. Physiology of thrombospondin. Ann. Rev. Med. 41: 85-97, 1990.
11. Varani, J., Riser, B. L., Hughes, L. A., Carey, T. E., Fligiel, S. E. G., and Dixit, V. M. Characterization of thrombospondin synthesis, secretion and cell surface expression by human tumor cells. Clin. Exp. Metastasis 7: 265-276, 1989.
12. Wight, T. N., Raugi, G. J., Mumby, S. M., and Bornstein, P. Light microscopic immunolocalization of thrombospondin in human tissues. J. Histochem. Cytochem. 33: 295-302, 1985.
13. Lawler, J., Duquett, M., Urry, L., McHenry, K., and Smith, T. F. The evolution of the thrombospondin gene family. J. Mol. Evol. 36: 509-516, 1993.
14. Tuszynski, G. P., Rothman, V. L., Murphy, A., Siegler, K., Smith, L., Karczewski, J., and Knudson, K. Thrombospondin promotes cell-substratum adhesion. Science, 236: 1570-1573, 1987.
15. Gasic, G. J., Tuszynski, G. P., and Gorelik, E. Interactions of the hemostatic and immune systems in the metastatic spread of tumor cells. Int. Rev. Exp. Pathol. 29: 173-212, 1986.
16. Tuszynski, G. P., Rothman, V. L., Murphy, A., Siegler, K., and Knudson, K. Thrombospondin promotes platelet aggregation. Blood 72: 109-115, 1988.
17. Murphy-Ullrich, J. E., and Hook, M. Thrombospondin modulates focal adhesions in endothelial cells. J. Cell Biol. 109: 1309-1319, 1989.
18. Taraboletti, G., Roberts, D. D., Liotta, L. A., and Giavazzi, R. Platelet thrombospondin modulates cell adhesion, motility, and growth: a potential angiogenesis regulatory factor. J. Cell Biol. 111: 765-772, 1990.
19. Nicosia, R. F., and Tuszynski, G. P. Matrix-bound thrombospondin promotes angiogenesis in vitro. J. Cell Biol. 124: 183-193, 1994.
20. Hosokawa, T., Akihiko, M., Rothman, V. L., and Tuszynski, G. P. The effect of thrombospondin on invasion of fibrin gels by human A549 lung carcinoma. Oncol. Res. 5: 183-189, 1993.
21. Albo, D., Arnoletti, J. P., Castiglioni, A., Granick, M. S., Solomon, M. P., Rothman, V. L., and Tuszynski, G. P. Thrombospondin and transforming growth factor beta promote human A549 lung carcinoma cell plasminogen activator inhibitor type 1 production and stimulate tumor cell attachment in vitro. Biochem. Biophys. Res. Commun. 203: 857-865, 1994.
22. Tuszynski, G. P., Gasic, T. B., Rothman, V. L., Knudson, K A., and Gasic, G. J. Thrombospondin, a potentiator of tumor cell metastasis. Cancer Res. 47: 4130-4133, 1987.
23. Pratt, D. A., Miller, W. R., and Dawes, J. Thrombospondin in malignant and non-malignant breast tissue. Eur. J. Cancer Clin. Oncol. 25: 343-345, 1989.
24. Tuszynski, G. P., Rothman, V. L., Papale, M., Hamilton, B. K., and Eyal, J. Identification and characterization of a tumor cell receptor for CSVTCG, a thrombospondin adhesive domain. J. Cell Biol. 120: 513-521, 1993.
25. Arnoletti, J. P., Albo, D., Nirag, J., Rothman, V. L., Granick, M. S., Solomon, M. P., and Tuszynski, G. P. Computer-assisted image analysis of tumor sections for a new thrombospondin receptor. Am. J. Surg. 168: 433-436, 1994.
26. Tuszynski, G. P., Smith, M., Rothman, V. L., Capuzzi, D. M., Joseph, R. R., Katz, J., Besa, M., Treat, J., and Switalska, H. I. Thrombospondin levels in patients with malignancy. Thromb. Haemostasis. 67: 607-611, 1992.
27. Albini, A., Iwamoto, Y., Kleinman, H. K., Martin, G. R., Aaronson, S. A., Kozlowski, J. M., and McEwan, R. N. A rapid in vitro assay for quantitating the invasive potential for tumor cells. Cancer Res. 47: 3239-3245, 1987.
28. Yabkowitz, R., Mansfield, P. J., Dixit, V. M., and Suchard, S. J. Motility of human carcinoma cells in response to thrombospondin: relationship to metastatic potential and thrombospondin structural domains. Cancer Res. 53: 378-387, 1993.
29. Clark, R. L. Systemic cancer and the metastatic process. Cancer 43: 790-797, 1979.
30. Flaumenhaft, R., Moscatelli, D., Saksela, O., and Rifkin, D. B. Role of extracellular matrix in the action of basic fibroblast growth factor. J. Cell. Physiol. 140: 75-81, 1989.
31. Testa, J. E., and Quigley, J. P. The role of urokinase-type plasminogen activator in aggressive tumor cell behavior. Cancer Metastasis Rev. 9: 353-67, 1990.
32. Vassalli, J. D., Sappino, A. P., and Belin, D. The plasminogen activator/plasmin system. J. Clin. Invest. 88: 1067-1172.
33. Kwaan, H. C. The plasminogen-plasmin system in malignancy. Cancer Metastasis Rev. 11: 291-311, 1992.
34. Mignatti, P., and Rifkin, D. B. Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev. 73: 161-195, 1993.
35. Krishnamurti, C., and Alving, B. Plasminogen activator inhibitor type 1: biochemistry and evidence for modulation of fibrinolysis in vivo. Semin. Thromb. Hemostasis 18: 67-80, 1992.
36. Arnoletti, J. P., Albo, D., Granick, M. S., Solomon, M. P., Castiglioni, A., Rothman, V. L., and Tuszynski, G. P. Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator Inhibitor-1 in human MDA-MB-231 breast cancer cells. Cancer 76: 998-1005, 1995.
37. Tuszynski, G. P., and Nicosia, R. F. Localization of thrombospondin and its cysteine-serine-valine-threonine-cysteine-glycine-specific receptor in human breast carcinoma. Lab. Invest. 70: 228-233, 1994.